OBJECTIVE: Compared to vegetable oils in their unmodified state, partially-hydrogenated fat is associated with less favorable effects on cardiovascular disease (CVD) risk factors. Acceptable alternatives must be adjudicated. Our objective was to assess the effect of a recent commercial fat substitution, corn oil for partially-hydrogenated soybean oil. METHODS: Using a double-blind cross-over design, 30 postmenopausal women >or=50 years with LDL-cholesterol concentrations >or=120 mg/dL were randomly assigned to each of two 35-day phases; all food and beverage was provided to maintain body weight. Corn or partially-hydrogenated soybean oil was incorporated throughout the diet and contributed two-thirds of fat. Primary outcomes included fasting and non-fasting lipid, lipoprotein, apolipoprotein, and fasting high sensitivity C-reactive protein (hsCRP) concentrations; secondary outcomes included fasting small dense LDL (sdLDL)-cholesterol, remnant lipoprotein cholesterol (RemLC), glycated albumin, adiponectin and immunoreactive insulin concentrations, and endogenous cholesteryl ester transfer protein (CETP) and lecithin:cholesterol acyl transferase (LCAT) activities. RESULTS: Relative to the partially-hydrogenated soybean oil enriched diet, the corn oil enriched diet resulted in lower fasting total cholesterol (7%; P<0.0001), LDL-cholesterol (10%; P<0.0001), VLDL-cholesterol (7%; P=0.052), apo B (9%; P<0.0001), lipoprotein (a) [Lp(a)] (5%; P=0.024), sdLDL-cholesterol (17%; P=0.001), and RemLC (20%; P=0.007) concentrations, and no significant effect on the other outcomes. Changes in postprandial (4-h post-meal) lipid, lipoprotein and apolipoprotein concentrations were similar to the fasting state. CONCLUSION: The replacement of partially-hydrogenated soybean oil with corn oil favorably affects a range of CVD risk factors and is an appropriate option to decrease cardiovascular disease risk factors in moderately hypercholesterolemic individuals.
RCT Entities:
OBJECTIVE: Compared to vegetable oils in their unmodified state, partially-hydrogenated fat is associated with less favorable effects on cardiovascular disease (CVD) risk factors. Acceptable alternatives must be adjudicated. Our objective was to assess the effect of a recent commercial fat substitution, cornoil for partially-hydrogenated soybeanoil. METHODS: Using a double-blind cross-over design, 30 postmenopausal women >or=50 years with LDL-cholesterol concentrations >or=120 mg/dL were randomly assigned to each of two 35-day phases; all food and beverage was provided to maintain body weight. Corn or partially-hydrogenated soybeanoil was incorporated throughout the diet and contributed two-thirds of fat. Primary outcomes included fasting and non-fasting lipid, lipoprotein, apolipoprotein, and fasting high sensitivity C-reactive protein (hsCRP) concentrations; secondary outcomes included fasting small dense LDL (sdLDL)-cholesterol, remnant lipoprotein cholesterol (RemLC), glycated albumin, adiponectin and immunoreactive insulin concentrations, and endogenous cholesteryl ester transfer protein (CETP) and lecithin:cholesterol acyl transferase (LCAT) activities. RESULTS: Relative to the partially-hydrogenated soybeanoil enriched diet, the cornoil enriched diet resulted in lower fasting total cholesterol (7%; P<0.0001), LDL-cholesterol (10%; P<0.0001), VLDL-cholesterol (7%; P=0.052), apo B (9%; P<0.0001), lipoprotein (a) [Lp(a)] (5%; P=0.024), sdLDL-cholesterol (17%; P=0.001), and RemLC (20%; P=0.007) concentrations, and no significant effect on the other outcomes. Changes in postprandial (4-h post-meal) lipid, lipoprotein and apolipoprotein concentrations were similar to the fasting state. CONCLUSION: The replacement of partially-hydrogenated soybeanoil with cornoil favorably affects a range of CVD risk factors and is an appropriate option to decrease cardiovascular disease risk factors in moderately hypercholesterolemic individuals.
Authors: Sung Nim Han; Lynette S Leka; Alice H Lichtenstein; Lynne M Ausman; Ernst J Schaefer; Simin Nikbin Meydani Journal: J Lipid Res Date: 2002-03 Impact factor: 5.922
Authors: A H Lichtenstein; M Jauhiainen; S McGladdery; L M Ausman; S M Jalbert; M Vilella-Bach; C Ehnholm; J Frohlich; E J Schaefer Journal: J Lipid Res Date: 2001-04 Impact factor: 5.922
Authors: Jean-François Mauger; Alice H Lichtenstein; Lynne M Ausman; Susan M Jalbert; Matti Jauhiainen; Christian Ehnholm; Benoît Lamarche Journal: Am J Clin Nutr Date: 2003-09 Impact factor: 7.045
Authors: Masumi Ai; Seiko Otokozawa; Bela F Asztalos; Yasuki Ito; Katsuyuki Nakajima; Charles C White; L Adrienne Cupples; Peter W Wilson; Ernst J Schaefer Journal: Clin Chem Date: 2010-04-29 Impact factor: 8.327
Authors: Nathalie T Bendsen; Steen Stender; Pal B Szecsi; Steen B Pedersen; Samar Basu; Lars I Hellgren; John W Newman; Thomas M Larsen; Steen B Haugaard; Arne Astrup Journal: J Lipid Res Date: 2011-07-27 Impact factor: 5.922
Authors: Frédéric Dutheil; Guillaume Walther; Robert Chapier; George Mnatzaganian; Bruno Lesourd; Geraldine Naughton; Julien Verney; Anne Fogli; Vincent Sapin; Martine Duclos; Agnès Vinet; Philippe Obert; Daniel Courteix; Gérard Lac Journal: Lipids Health Dis Date: 2014-07-11 Impact factor: 3.876
Authors: Emma E McGee; Claire H Kim; Molin Wang; Donna Spiegelman; Daniel G Stover; Yujing J Heng; Laura C Collins; Gabrielle M Baker; Maryam S Farvid; Pepper Schedin; Sonali Jindal; Rulla M Tamimi; A Heather Eliassen Journal: Breast Cancer Res Date: 2020-07-22 Impact factor: 6.466